A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Trial details
- Registry ID
- NCT07211776
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye DiseaseNCT07211776 | Zai Lab (Shanghai) Co., Ltd. | Phase 3 | Active not recruiting | 2027-03-14Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |